Celularity Inc. (NASDAQ: GXGX) Stock Competitors & Peer Comparison

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, CCIV has a market cap of 44.4B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while CCIV trades at $24.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas CCIV's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to CCIV's ROE of -13.92%. Regarding short-term risk, GXGX is more volatile compared to CCIV. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check CCIV's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, PSACU has a market cap of 12B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while PSACU trades at $17.08.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas PSACU's P/E ratio is -108.79. In terms of profitability, GXGX's ROE is +4.12%, compared to PSACU's ROE of -35.44%. Regarding short-term risk, GXGX is more volatile compared to PSACU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check PSACU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, RTPY has a market cap of 11.6B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while RTPY trades at $9.91.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas RTPY's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to RTPY's ROE of -0.43%. Regarding short-term risk, GXGX is more volatile compared to RTPY. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check RTPY's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, LVRAW has a market cap of 11.5B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while LVRAW trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas LVRAW's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to LVRAW's ROE of N/A. Regarding short-term risk, GXGX is less volatile compared to LVRAW. This indicates lower risk in terms of short-term price fluctuations for GXGX.Check LVRAW's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, CMLFU has a market cap of 10.3B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while CMLFU trades at $13.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas CMLFU's P/E ratio is -1444.44. In terms of profitability, GXGX's ROE is +4.12%, compared to CMLFU's ROE of -0.39%. Regarding short-term risk, GXGX is more volatile compared to CMLFU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check CMLFU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, PSAC has a market cap of 9.7B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while PSAC trades at $13.78.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas PSAC's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to PSAC's ROE of -35.44%. Regarding short-term risk, GXGX is more volatile compared to PSAC. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check PSAC's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, GRSVU has a market cap of 6.8B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while GRSVU trades at $11.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas GRSVU's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to GRSVU's ROE of +0.00%. Regarding short-term risk, GXGX is more volatile compared to GRSVU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check GRSVU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, APSG has a market cap of 6.3B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while APSG trades at $7.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas APSG's P/E ratio is 36.95. In terms of profitability, GXGX's ROE is +4.12%, compared to APSG's ROE of +0.03%. Regarding short-term risk, GXGX is more volatile compared to APSG. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check APSG's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, RTP has a market cap of 6.3B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while RTP trades at $10.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas RTP's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to RTP's ROE of -0.58%. Regarding short-term risk, GXGX is more volatile compared to RTP. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check RTP's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, DGNR has a market cap of 5.8B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while DGNR trades at $9.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas DGNR's P/E ratio is -308.67. In terms of profitability, GXGX's ROE is +4.12%, compared to DGNR's ROE of +0.02%. Regarding short-term risk, GXGX is more volatile compared to DGNR. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check DGNR's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, VTIQ has a market cap of 5.6B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while VTIQ trades at $10.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas VTIQ's P/E ratio is 91.50. In terms of profitability, GXGX's ROE is +4.12%, compared to VTIQ's ROE of +472.81%. Regarding short-term risk, GXGX is more volatile compared to VTIQ. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check VTIQ's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, VTIQU has a market cap of 5.6B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while VTIQU trades at $10.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas VTIQU's P/E ratio is 100.60. In terms of profitability, GXGX's ROE is +4.12%, compared to VTIQU's ROE of +472.81%. Regarding short-term risk, GXGX is more volatile compared to VTIQU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check VTIQU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, VACQ has a market cap of 5.5B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while VACQ trades at $11.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas VACQ's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to VACQ's ROE of -0.12%. Regarding short-term risk, GXGX is more volatile compared to VACQ. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check VACQ's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, SVFC has a market cap of 5.1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while SVFC trades at $9.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas SVFC's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to SVFC's ROE of +0.05%. Regarding short-term risk, GXGX is more volatile compared to SVFC. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check SVFC's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, VGAC has a market cap of 5B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while VGAC trades at $10.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas VGAC's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to VGAC's ROE of -1.21%. Regarding short-term risk, GXGX is more volatile compared to VGAC. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check VGAC's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, CMLT has a market cap of 4.2B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while CMLT trades at $8.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas CMLT's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to CMLT's ROE of N/A. Regarding short-term risk, GXGX is more volatile compared to CMLT. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check CMLT's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, GHVI has a market cap of 4.2B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while GHVI trades at $14.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas GHVI's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to GHVI's ROE of -1.28%. Regarding short-term risk, GXGX is more volatile compared to GHVI. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check GHVI's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, KVSB has a market cap of 4.2B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while KVSB trades at $11.12.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas KVSB's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to KVSB's ROE of -0.07%. Regarding short-term risk, GXGX is more volatile compared to KVSB. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check KVSB's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, FTOCU has a market cap of 4.1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while FTOCU trades at $11.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas FTOCU's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to FTOCU's ROE of +0.07%. Regarding short-term risk, GXGX is more volatile compared to FTOCU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check FTOCU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, THCBU has a market cap of 3.9B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while THCBU trades at $12.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas THCBU's P/E ratio is -101.87. In terms of profitability, GXGX's ROE is +4.12%, compared to THCBU's ROE of -0.23%. Regarding short-term risk, GXGX is more volatile compared to THCBU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check THCBU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, CLII has a market cap of 3.8B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while CLII trades at $14.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas CLII's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to CLII's ROE of -0.31%. Regarding short-term risk, GXGX is more volatile compared to CLII. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check CLII's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, GRNV has a market cap of 3.8B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while GRNV trades at $12.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas GRNV's P/E ratio is -59.68. In terms of profitability, GXGX's ROE is +4.12%, compared to GRNV's ROE of +0.05%. Regarding short-term risk, GXGX is more volatile compared to GRNV. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check GRNV's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, FRX has a market cap of 3.7B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while FRX trades at $12.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas FRX's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to FRX's ROE of +0.19%. Regarding short-term risk, GXGX is more volatile compared to FRX. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check FRX's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, HOLUU has a market cap of 3.7B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while HOLUU trades at $13.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas HOLUU's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to HOLUU's ROE of -0.13%. Regarding short-term risk, GXGX is more volatile compared to HOLUU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check HOLUU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, SSPK has a market cap of 3.4B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while SSPK trades at $18.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas SSPK's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to SSPK's ROE of +0.04%. Regarding short-term risk, GXGX is more volatile compared to SSPK. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check SSPK's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, FCACU has a market cap of 3.4B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while FCACU trades at $9.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas FCACU's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to FCACU's ROE of -0.00%. Regarding short-term risk, GXGX is more volatile compared to FCACU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check FCACU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, CFVI has a market cap of 3.4B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while CFVI trades at $12.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas CFVI's P/E ratio is -18.55. In terms of profitability, GXGX's ROE is +4.12%, compared to CFVI's ROE of +0.00%. Regarding short-term risk, GXGX is more volatile compared to CFVI. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check CFVI's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, HOL has a market cap of 3.3B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while HOL trades at $12.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas HOL's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to HOL's ROE of -0.13%. Regarding short-term risk, GXGX is more volatile compared to HOL. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check HOL's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, CCXIW has a market cap of 3.2B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while CCXIW trades at $8.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas CCXIW's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to CCXIW's ROE of N/A. Regarding short-term risk, GXGX is more volatile compared to CCXIW. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check CCXIW's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, THCB has a market cap of 3.1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while THCB trades at $10.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas THCB's P/E ratio is -81.30. In terms of profitability, GXGX's ROE is +4.12%, compared to THCB's ROE of -0.23%. Regarding short-term risk, GXGX is more volatile compared to THCB. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check THCB's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, SOAC has a market cap of 2.8B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while SOAC trades at $10.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas SOAC's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to SOAC's ROE of +3.51%. Regarding short-term risk, GXGX is more volatile compared to SOAC. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check SOAC's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, DCRBU has a market cap of 2.8B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while DCRBU trades at $11.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas DCRBU's P/E ratio is -16.00. In terms of profitability, GXGX's ROE is +4.12%, compared to DCRBU's ROE of -0.84%. Regarding short-term risk, GXGX is more volatile compared to DCRBU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check DCRBU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, IVAN has a market cap of 2.7B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while IVAN trades at $7.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas IVAN's P/E ratio is -698.18. In terms of profitability, GXGX's ROE is +4.12%, compared to IVAN's ROE of -0.32%. Regarding short-term risk, GXGX is more volatile compared to IVAN. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check IVAN's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, GWAC has a market cap of 2.6B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while GWAC trades at $10.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas GWAC's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to GWAC's ROE of -0.59%. Regarding short-term risk, GXGX is more volatile compared to GWAC. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check GWAC's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, LCYAU has a market cap of 2.6B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while LCYAU trades at $13.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas LCYAU's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to LCYAU's ROE of +0.04%. Regarding short-term risk, GXGX is more volatile compared to LCYAU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check LCYAU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, FWAA has a market cap of 2.4B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while FWAA trades at $12.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas FWAA's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to FWAA's ROE of -0.09%. Regarding short-term risk, GXGX is more volatile compared to FWAA. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check FWAA's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, GSAH has a market cap of 2.4B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while GSAH trades at $10.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas GSAH's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to GSAH's ROE of +0.42%. Regarding short-term risk, GXGX is more volatile compared to GSAH. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check GSAH's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, LCY has a market cap of 2.4B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while LCY trades at $12.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas LCY's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to LCY's ROE of +0.04%. Regarding short-term risk, GXGX is more volatile compared to LCY. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check LCY's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, FORE has a market cap of 2.3B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while FORE trades at $9.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas FORE's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to FORE's ROE of +4.34%. Regarding short-term risk, GXGX is more volatile compared to FORE. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check FORE's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, RAAC has a market cap of 2.2B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while RAAC trades at $9.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas RAAC's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to RAAC's ROE of +0.00%. Regarding short-term risk, GXGX is more volatile compared to RAAC. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check RAAC's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, SPNV has a market cap of 2.2B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while SPNV trades at $8.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas SPNV's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to SPNV's ROE of -0.99%. Regarding short-term risk, GXGX is more volatile compared to SPNV. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check SPNV's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, DNAC has a market cap of 2.2B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while DNAC trades at $9.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas DNAC's P/E ratio is -37.72. In terms of profitability, GXGX's ROE is +4.12%, compared to DNAC's ROE of -0.34%. Regarding short-term risk, GXGX is more volatile compared to DNAC. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check DNAC's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, FAII has a market cap of 2.1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while FAII trades at $10.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas FAII's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to FAII's ROE of -0.32%. Regarding short-term risk, GXGX is more volatile compared to FAII. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check FAII's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, DMYI has a market cap of 2.1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while DMYI trades at $10.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas DMYI's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to DMYI's ROE of -0.16%. Regarding short-term risk, GXGX is more volatile compared to DMYI. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check DMYI's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, LOKB has a market cap of 2.1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while LOKB trades at $13.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas LOKB's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to LOKB's ROE of -0.62%. Regarding short-term risk, GXGX is more volatile compared to LOKB. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check LOKB's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, STPC has a market cap of 2B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while STPC trades at $9.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas STPC's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to STPC's ROE of -0.29%. Regarding short-term risk, GXGX is more volatile compared to STPC. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check STPC's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, MUDS has a market cap of 2B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while MUDS trades at $10.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas MUDS's P/E ratio is 3.39. In terms of profitability, GXGX's ROE is +4.12%, compared to MUDS's ROE of -0.01%. Regarding short-term risk, GXGX is more volatile compared to MUDS. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check MUDS's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, MUDSU has a market cap of 2B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while MUDSU trades at $10.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas MUDSU's P/E ratio is -1125.56. In terms of profitability, GXGX's ROE is +4.12%, compared to MUDSU's ROE of -0.01%. Regarding short-term risk, GXGX is more volatile compared to MUDSU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check MUDSU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, TINV has a market cap of 2B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while TINV trades at $11.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas TINV's P/E ratio is 30.61. In terms of profitability, GXGX's ROE is +4.12%, compared to TINV's ROE of +1.23%. Regarding short-term risk, GXGX is more volatile compared to TINV. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check TINV's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, APXT has a market cap of 1.9B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while APXT trades at $10.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas APXT's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to APXT's ROE of +0.16%. Regarding short-term risk, GXGX is more volatile compared to APXT. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check APXT's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, APXTU has a market cap of 1.9B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while APXTU trades at $10.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas APXTU's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to APXTU's ROE of +0.16%. Regarding short-term risk, GXGX is more volatile compared to APXTU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check APXTU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, DWAC has a market cap of 1.9B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while DWAC trades at $49.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas DWAC's P/E ratio is -73.46. In terms of profitability, GXGX's ROE is +4.12%, compared to DWAC's ROE of -0.58%. Regarding short-term risk, GXGX is more volatile compared to DWAC. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check DWAC's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, DWACU has a market cap of 1.9B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while DWACU trades at $61.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas DWACU's P/E ratio is -451.10. In terms of profitability, GXGX's ROE is +4.12%, compared to DWACU's ROE of -0.58%. Regarding short-term risk, GXGX is more volatile compared to DWACU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check DWACU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, ATHN has a market cap of 1.8B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while ATHN trades at $9.59.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas ATHN's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to ATHN's ROE of +2.24%. Regarding short-term risk, GXGX is more volatile compared to ATHN. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check ATHN's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, APXTW has a market cap of 1.8B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while APXTW trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas APXTW's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to APXTW's ROE of +0.16%. Regarding short-term risk, GXGX is more volatile compared to APXTW. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check APXTW's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, GMII has a market cap of 1.8B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while GMII trades at $8.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas GMII's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to GMII's ROE of +0.21%. Regarding short-term risk, GXGX is more volatile compared to GMII. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check GMII's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, MOTV has a market cap of 1.7B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while MOTV trades at $10.11.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas MOTV's P/E ratio is 55.86. In terms of profitability, GXGX's ROE is +4.12%, compared to MOTV's ROE of -0.23%. Regarding short-term risk, GXGX is more volatile compared to MOTV. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check MOTV's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, CBAH has a market cap of 1.7B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while CBAH trades at $10.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas CBAH's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to CBAH's ROE of +0.04%. Regarding short-term risk, GXGX is more volatile compared to CBAH. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check CBAH's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, GXGXU has a market cap of 1.7B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while GXGXU trades at $11.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas GXGXU's P/E ratio is -23.73. In terms of profitability, GXGX's ROE is +4.12%, compared to GXGXU's ROE of -0.03%. Regarding short-term risk, GXGX is more volatile compared to GXGXU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check GXGXU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, AONE has a market cap of 1.7B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while AONE trades at $8.56.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas AONE's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to AONE's ROE of -17.11%. Regarding short-term risk, GXGX is more volatile compared to AONE. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check AONE's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, SNPR has a market cap of 1.6B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while SNPR trades at $9.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas SNPR's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to SNPR's ROE of +0.00%. Regarding short-term risk, GXGX is more volatile compared to SNPR. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check SNPR's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, SPFR has a market cap of 1.6B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while SPFR trades at $8.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas SPFR's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to SPFR's ROE of -4.58%. Regarding short-term risk, GXGX is more volatile compared to SPFR. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check SPFR's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, DEH has a market cap of 1.6B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while DEH trades at $11.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas DEH's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to DEH's ROE of -3.33%. Regarding short-term risk, GXGX is more volatile compared to DEH. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check DEH's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, ROT has a market cap of 1.6B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while ROT trades at $10.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas ROT's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to ROT's ROE of -0.45%. Regarding short-term risk, GXGX is more volatile compared to ROT. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check ROT's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, NGAC has a market cap of 1.5B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while NGAC trades at $8.83.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas NGAC's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to NGAC's ROE of -0.87%. Regarding short-term risk, GXGX is more volatile compared to NGAC. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check NGAC's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, HECCU has a market cap of 1.4B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while HECCU trades at $9.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas HECCU's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to HECCU's ROE of -0.10%. Regarding short-term risk, GXGX is more volatile compared to HECCU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check HECCU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, ATMR has a market cap of 1.4B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while ATMR trades at $10.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas ATMR's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to ATMR's ROE of +0.44%. Regarding short-term risk, GXGX is more volatile compared to ATMR. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check ATMR's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, SFTW has a market cap of 1.4B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while SFTW trades at $11.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas SFTW's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to SFTW's ROE of -0.56%. Regarding short-term risk, GXGX is more volatile compared to SFTW. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check SFTW's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, ENFA has a market cap of 1.3B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while ENFA trades at $9.62.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas ENFA's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to ENFA's ROE of -1.15%. Regarding short-term risk, GXGX is more volatile compared to ENFA. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check ENFA's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, ENVI has a market cap of 1.3B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while ENVI trades at $8.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas ENVI's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to ENVI's ROE of +0.00%. Regarding short-term risk, GXGX is more volatile compared to ENVI. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check ENVI's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, ACTD has a market cap of 1.3B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while ACTD trades at $7.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas ACTD's P/E ratio is -25.50. In terms of profitability, GXGX's ROE is +4.12%, compared to ACTD's ROE of +0.00%. Regarding short-term risk, GXGX is more volatile compared to ACTD. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check ACTD's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, VCKA has a market cap of 1.3B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while VCKA trades at $9.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas VCKA's P/E ratio is 100.11. In terms of profitability, GXGX's ROE is +4.12%, compared to VCKA's ROE of +1.68%. Regarding short-term risk, GXGX is more volatile compared to VCKA. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check VCKA's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, THMA has a market cap of 1.3B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while THMA trades at $9.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas THMA's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to THMA's ROE of +0.00%. Regarding short-term risk, GXGX is more volatile compared to THMA. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check THMA's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, LNFA has a market cap of 1.3B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while LNFA trades at $10.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas LNFA's P/E ratio is 21.06. In terms of profitability, GXGX's ROE is +4.12%, compared to LNFA's ROE of +0.09%. Regarding short-term risk, GXGX is more volatile compared to LNFA. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check LNFA's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, FTIVU has a market cap of 1.3B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while FTIVU trades at $14.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas FTIVU's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to FTIVU's ROE of -0.14%. Regarding short-term risk, GXGX is more volatile compared to FTIVU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check FTIVU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, STWO has a market cap of 1.3B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while STWO trades at $8.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas STWO's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to STWO's ROE of +0.00%. Regarding short-term risk, GXGX is more volatile compared to STWO. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check STWO's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, HYACU has a market cap of 1.2B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while HYACU trades at $10.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas HYACU's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to HYACU's ROE of -0.11%. Regarding short-term risk, GXGX is more volatile compared to HYACU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check HYACU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, FTIV has a market cap of 1.2B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while FTIV trades at $13.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas FTIV's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to FTIV's ROE of -0.14%. Regarding short-term risk, GXGX is more volatile compared to FTIV. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check FTIV's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, AHAC has a market cap of 1.1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while AHAC trades at $10.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas AHAC's P/E ratio is -72.11. In terms of profitability, GXGX's ROE is +4.12%, compared to AHAC's ROE of -16.18%. Regarding short-term risk, GXGX is more volatile compared to AHAC. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check AHAC's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, AMHC has a market cap of 1.1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while AMHC trades at $10.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas AMHC's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to AMHC's ROE of +0.00%. Regarding short-term risk, GXGX is more volatile compared to AMHC. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check AMHC's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, HERAW has a market cap of 1.1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while HERAW trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas HERAW's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to HERAW's ROE of +0.01%. Regarding short-term risk, GXGX is less volatile compared to HERAW. This indicates lower risk in terms of short-term price fluctuations for GXGX.Check HERAW's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, HERA has a market cap of 1.1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while HERA trades at $10.19.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas HERA's P/E ratio is 46.32. In terms of profitability, GXGX's ROE is +4.12%, compared to HERA's ROE of +0.01%. Regarding short-term risk, GXGX is more volatile compared to HERA. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check HERA's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, FGNA has a market cap of 1.1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while FGNA trades at $9.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas FGNA's P/E ratio is -4.35. In terms of profitability, GXGX's ROE is +4.12%, compared to FGNA's ROE of +0.71%. Regarding short-term risk, GXGX is more volatile compared to FGNA. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check FGNA's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, DNAA has a market cap of 1.1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while DNAA trades at $14.07.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas DNAA's P/E ratio is -54.53. In terms of profitability, GXGX's ROE is +4.12%, compared to DNAA's ROE of +0.00%. Regarding short-term risk, GXGX is less volatile compared to DNAA. This indicates lower risk in terms of short-term price fluctuations for GXGX.Check DNAA's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, RACA has a market cap of 1.1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while RACA trades at $10.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas RACA's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to RACA's ROE of +0.00%. Regarding short-term risk, GXGX is more volatile compared to RACA. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check RACA's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, TREB has a market cap of 1.1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while TREB trades at $9.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas TREB's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to TREB's ROE of -12.26%. Regarding short-term risk, GXGX is more volatile compared to TREB. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check TREB's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, PACE has a market cap of 1.1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while PACE trades at $11.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas PACE's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to PACE's ROE of -1.52%. Regarding short-term risk, GXGX is more volatile compared to PACE. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check PACE's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, HERAU has a market cap of 1.1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while HERAU trades at $10.16.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas HERAU's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to HERAU's ROE of +0.01%. Regarding short-term risk, GXGX is more volatile compared to HERAU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check HERAU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, LSAQ has a market cap of 1.1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while LSAQ trades at $9.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas LSAQ's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to LSAQ's ROE of N/A. Regarding short-term risk, GXGX is more volatile compared to LSAQ. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check LSAQ's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, SRAC has a market cap of 1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while SRAC trades at $10.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas SRAC's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to SRAC's ROE of -4.03%. Regarding short-term risk, GXGX is more volatile compared to SRAC. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check SRAC's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, FTPAW has a market cap of 1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while FTPAW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas FTPAW's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to FTPAW's ROE of -0.00%. Regarding short-term risk, GXGX is more volatile compared to FTPAW. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check FTPAW's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, SBG has a market cap of 1B. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while SBG trades at $8.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas SBG's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to SBG's ROE of -3.15%. Regarding short-term risk, GXGX is more volatile compared to SBG. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check SBG's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, CVII-WT has a market cap of 977.9M. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while CVII-WT trades at $0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas CVII-WT's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to CVII-WT's ROE of +0.02%. Regarding short-term risk, GXGX is more volatile compared to CVII-WT. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check CVII-WT's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, BBCQW has a market cap of 977.6M. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while BBCQW trades at $1.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas BBCQW's P/E ratio is N/A. In terms of profitability, GXGX's ROE is +4.12%, compared to BBCQW's ROE of N/A. Regarding short-term risk, GXGX is more volatile compared to BBCQW. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check BBCQW's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, CVII-UN has a market cap of 958.8M. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while CVII-UN trades at $10.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas CVII-UN's P/E ratio is 64.65. In terms of profitability, GXGX's ROE is +4.12%, compared to CVII-UN's ROE of +0.02%. Regarding short-term risk, GXGX is more volatile compared to CVII-UN. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check CVII-UN's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, BRPM has a market cap of 944M. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while BRPM trades at $13.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas BRPM's P/E ratio is -72.74. In terms of profitability, GXGX's ROE is +4.12%, compared to BRPM's ROE of +4.56%. Regarding short-term risk, GXGX is more volatile compared to BRPM. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check BRPM's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, CRSAU has a market cap of 937.8M. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while CRSAU trades at $10.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas CRSAU's P/E ratio is -27.21. In terms of profitability, GXGX's ROE is +4.12%, compared to CRSAU's ROE of -0.34%. Regarding short-term risk, GXGX is more volatile compared to CRSAU. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check CRSAU's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, CVII has a market cap of 914.7M. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while CVII trades at $9.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas CVII's P/E ratio is 999.00. In terms of profitability, GXGX's ROE is +4.12%, compared to CVII's ROE of +0.02%. Regarding short-term risk, GXGX is more volatile compared to CVII. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check CVII's competition here

Celularity Inc. (NASDAQ: GXGX) plays a significant role within the Financial Services sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, GXGX stands at 1.5B. In comparison, BCTG has a market cap of 899.4M. Regarding current trading prices, GXGX is priced at $10.20 on the NASDAQ, while BCTG trades at $10.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

GXGX currently has a P/E ratio of N/A, whereas BCTG's P/E ratio is -204.00. In terms of profitability, GXGX's ROE is +4.12%, compared to BCTG's ROE of -0.42%. Regarding short-term risk, GXGX is more volatile compared to BCTG. This indicates higher risk in terms of short-term price fluctuations for GXGX.Check BCTG's competition here